Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $209,010 - $232,560
1,000 New
1,000 $218,000
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $31,162 - $34,363
155 Added 7.05%
2,355 $473,000
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $466,246 - $530,926
2,200 New
2,200 $530,000
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $714,649 - $873,386
-3,508 Reduced 63.69%
2,000 $470,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $634,911 - $812,789
3,100 Added 128.74%
5,508 $1.13 Million
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $514,974 - $669,110
2,408 New
2,408 $564,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.